Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Omicron variant of SARS-CoV-2 is less infectious in dogs and cats

Omicron variant of SARS-CoV-2 is less infectious in dogs and cats

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

Over 50% of cancer patients report long COVID symptoms after recovering from COVID-19

Over 50% of cancer patients report long COVID symptoms after recovering from COVID-19

Influenza A virus suppresses SARS-CoV-2 replication during co-infection

Influenza A virus suppresses SARS-CoV-2 replication during co-infection

Similar autoantibody profiles in long COVID and fully recovered individuals

Similar autoantibody profiles in long COVID and fully recovered individuals

SARS-CoV-2 infection and Ad26.COV2.S vaccination may increase risk of stroke post-vaccination

SARS-CoV-2 infection and Ad26.COV2.S vaccination may increase risk of stroke post-vaccination

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

Fear and anxiety during the COVID-19 pandemic associated with new alcohol use disorder diagnoses

Fear and anxiety during the COVID-19 pandemic associated with new alcohol use disorder diagnoses

Bivalent booster recipients show slightly higher protection against infection and significantly higher protection against death than monovalent booster recipients

Bivalent booster recipients show slightly higher protection against infection and significantly higher protection against death than monovalent booster recipients

Whole-genome CRISPR activation for the identification of host factors controlling cellular interactions with SARS-CoV-2

Whole-genome CRISPR activation for the identification of host factors controlling cellular interactions with SARS-CoV-2

Dietary inflammation linked to worse outcomes in COVID-19

Dietary inflammation linked to worse outcomes in COVID-19

No new SARS-CoV-2 variants detected in China since COVID policy change

No new SARS-CoV-2 variants detected in China since COVID policy change

Pegylated interferon lambda shows good efficacy against COVID-19

Pegylated interferon lambda shows good efficacy against COVID-19

Study suggests SARS-CoV-2 is likely to only infect placental mammals

Study suggests SARS-CoV-2 is likely to only infect placental mammals

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection

Study demonstrates antiviral effects of vinegar against SARS-CoV-2

Study demonstrates antiviral effects of vinegar against SARS-CoV-2

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Assessing the zoonotic potential of different coronaviruses in hedgehogs, moles and shrews

Assessing the zoonotic potential of different coronaviruses in hedgehogs, moles and shrews

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.